Clinical Trials Sponsored by ActiveLife Scientific

Total 2003 results

Moscow Clinical Scientific Center

Recruiting

Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

Breast Cancer | Pancreas Cancer

Russian Federation
i-Lumen Scientific, Inc.

Recruiting

Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) (i-SIGHT)

Age-Related Macular Degeneration | Dry Age-related Macular Degeneration | Nonexudative Age-related Macular Degeneration

United States
Acotec Scientific Co., Ltd

Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries.

Peripheral Arterial Disease (PAD) | Peripheral Vascular Disease (PVD)

China
Acotec Scientific Co., Ltd

Recruiting

ACOART BTK RENEW：A Post Market Clinical Study

Peripheral Artery Disease

China
Janssen Scientific Affairs, LLC

Recruiting

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

Crohn Disease | Colitis, Ulcerative

United States
Janssen Scientific Affairs, LLC

Active, not recruiting

Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Psoriasis

United States, Australia, Ukraine, Belgium, Taiwan, Spain, Austria, Colombia, Israel, Portugal, Slovenia, Japan, Canada, Greece, Korea, Republic of, Argentina, Chile, Netherlands, Sweden, Slovakia, Czechia, Mexico
Janssen Scientific Affairs, LLC

Completed

A Study of JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma

Multiple Myeloma

United States
Janssen Scientific Affairs, LLC

Available

Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma

Multiple Myeloma
Janssen Scientific Affairs, LLC

Completed

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year (SEAVUE)

Crohn Disease

United States, Belgium, Korea, Republic of, Netherlands, Italy, United Kingdom, Canada, France, Australia, Bulgaria, Poland, Germany, Serbia, Czechia, Russian Federation, Spain, Brazil, Hungary
Janssen Scientific Affairs, LLC

Completed

A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care

HIV-1

United States
Janssen Scientific Affairs, LLC

Terminated

A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation (QUANTUM AF)

Atrial Fibrillation

United States
Scientific Institute San Raffaele

Completed

Vitamin K2 for Reduction the Calcium at Carotid Bifurcation in Patients With Subcritical Lesions

Carotid Plaques

Italy
Scientific Institute San Raffaele

Completed

Neurophysiological Intraoperative Monitoring During Aortic Surgery (NIMAS)

Aortic Aneurysm, Thoracic

Italy
Janssen Scientific Affairs, LLC

Approved for marketing

Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations Who Have Exhausted All Treatment Options

Advanced Cancers and FGFR Genetic Alterations
Janssen Scientific Affairs, LLC

Completed

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) (FIRST)

Schizophrenia

United States
Janssen Scientific Affairs, LLC

Completed

Velcade (Bortezomib) Consolidation After Transplant (VCAT)

Multiple Myeloma

Australia, China, Korea, Republic of
Moscow Clinical Scientific Center

Completed

RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma | Hilar Cholangiocarcinoma
Scientific Institute San Raffaele

Unknown

The Impact on Ovarian Reserve of Ovarian Cystectomy Versus Laser Vaporization in the Treatment of Ovarian Endometrioma: a Randomized Clinical Trial (Laser)

Endometrioma

Italy, Poland
Janssen Scientific Affairs, LLC

Completed

Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents

Hypertension | Diabetes Mellitus, Type 2

United States, Puerto Rico
Janssen Scientific Affairs, LLC

Completed

An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant (GALAXY)

Hepatitits C

United States
Palmaz Scientific
ClinLogix. LLC

Completed

Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study

Ischemic Heart Disease
Acotec Scientific Co., Ltd

Completed

Effectiveness and Safety Study of Peripheral Balloon Dilatation Catheter in Percutaneous Transluminal Angioplasty(PTA) Procedure

Peripheral Arterial Disease

China
Scientific Institute San Raffaele

Completed

Comparison Between Excisional Hemorrhoidectomy and Haemorrhoidal Dearterialisation With Anopexy

Third Degree Hemorrhoids

Italy
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

Exploratory Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm

Thoracoabdominal Aortic Aneurysm

China
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis

Cholestasis, Intrahepatic

Russian Federation
Lifetech Scientific (Shenzhen) Co., Ltd.

Not yet recruiting

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

Atrial Septal Defect

Italy, Brazil, Greece
Convexity Scientific Inc
Hartford HealthCare

Recruiting

Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions (POWER)

Lung Diseases | Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | COPD | Respiratory Tract Disease

United States
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm.

Thoracoabdominal Aortic Aneurysms

China
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events

Non-valvular Atrial Fibrillation | Embolic Stroke

China
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

Lifetech LAmbre™ Left Atrial Appendage Closure System Post-Market Registry

Atrial Fibrillation

Germany
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

A First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System

Single Coronary Vessel Disease

Malaysia
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients

Atrial Septal Defect | Heart Septal Defects, Atrial

China
Thermo Fisher Scientific, Inc
NAMSA

Completed

Project STARFISH - PRJ0002679 (STARFISH)

SARS-CoV-2 Infection | Influenza A | RSV Infection | Influenza Type B

United States
Duke University
Boston Scientific Corporation

Enrolling by invitation

Conduction System Pacing With INGEVITY+ (INSIGHT-LBBA)

Bradycardia

United States
Ceric Sàrl
Boston Scientific Corporation

Completed

Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization. (SENIOR)

Acute Coronary Syndrome | Stable Angina | Silent Myocardial Ischemia

France, Spain, Belgium, Switzerland, United Kingdom, Latvia, Finland, Italy, North Macedonia
Ministry of Scientific Research, Tunisia

Active, not recruiting

TAP Block Versus Conventional Systemic Analgesia (TAPLAP)

Analgesia

Tunisia
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Cytoflavin in Combination With Reperfusion in Stroke Patients

Acute Stroke

Russian Federation
Lifetech Scientific (Shenzhen) Co., Ltd.

Withdrawn

Safety and Efficacy of IrisFIT™ Patent Foramen Ovale Occluders

Patent Foramen Ovale | Cryptogenic Stroke

China
Symetis SA

Completed

ACURATE Neo™ TA Delivery System in Patient With Severe Aortic Stenosis

Aortic Stenosis

Germany
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy (CYLINDER)

Diabetic Neuropathies

Russian Federation
Tokai University
Boston Scientific Corporation

Enrolling by invitation

Single Catheter Primary Percutaneous Coronary Intervention Method in Patients With ST Elevation Myocardial Infarction (SPEEDYPCI)

ST Elevation Myocardial Infarction

Japan
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA Modul 7 VRR

Atrial Fibrillation

Germany
POLYSAN Scientific & Technological Pharmaceutical...

Completed

Cytoflavin in the Rehabilitation of Post-intensive Care Syndrome in Stroke Survivors

Ischemic Stroke | Post Intensive Care Unit Syndrome

Russian Federation
Bayer
Janssen Scientific Affairs, LLC

Completed

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Venous Thrombosis | Atrial Fibrillation | Acute Coronary Syndrome | Pulmonary Embolism

Netherlands
Boston Scientific Corporation
EKOS Corporation

Completed

ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA)

Submassive Pulmonary Embolism

Germany, Switzerland
Boston Scientific Corporation
EKOS Corporation

Completed

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism (OPTALYSE PE)

Pulmonary Embolism and Thrombosis

United States, United Kingdom
Boston Scientific Corporation
PneumRx, Inc.

Terminated

Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study (RENEW)

Emphysema

United States, Netherlands, France, Canada, Germany, United Kingdom
Boston Scientific Corporation
EKOS Corporation

Completed

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (SEATTLE II)

Pulmonary Embolism | Acute Pulmonary Embolism | Pulmonary Thromboembolism | Massive Pulmonary Embolism | Sub-massive Pulmonary Embolism

United States
Boston Scientific Corporation
PneumRx, Inc.

Completed

Evaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Subjects With Homogeneous Emphysema

Emphysema

Netherlands
Boston Scientific Corporation
Augmenix, Inc.

Completed

SpaceOAR System Pivotal Study

Prostate Cancer

United States

Clinical Trials Sponsored by ActiveLife Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations